ArticleNPJ precision oncology2021

High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition.

Ying Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.